SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-20-001755
Filing Date
2020-04-07
Accepted
2020-04-07 11:14:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SONNET BIOTHERAPEUTICS HOLDINGS, INC. p20-0893sc13g.htm SC 13G 95663
  Complete submission text file 0000902664-20-001755.txt   97372
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Subject) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81795 | Film No.: 20778784
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G